Increase in Incident Anemia Seen With Low-Dose Aspirin in Older Adults
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, June 20, 2023 -- For older adults, low-dose aspirin is associated with increased incident anemia and a decrease in ferritin when compared with placebo, according to a study published online June 20 in the Annals of Internal Medicine.
Zoe K. McQuilten, M.B.B.S., Ph.D., from Monash University in Melbourne, Australia, and colleagues examined the effect of low-dose aspirin on incident anemia, hemoglobin, and serum ferritin concentrations in a post hoc analysis of the ASPirin in Reducing Events in the Elderly trial involving community-dwelling individuals aged 70 years or older. A total of 19,114 individuals were randomly assigned to 100 mg of aspirin daily or placebo.
The researchers found that the incidence of anemia was 51.2 events per 1,000 person-years and 42.9 events per 1,000 person-years in the aspirin and placebo groups, respectively (hazard ratio, 1.20). In the placebo group, hemoglobin concentrations decreased by 3.6 g/L per five years, while a steeper decline of 0.6 g/L per five years was experienced by the aspirin group. In 7,139 participants with ferritin measures at baseline and year 3, the prevalence of ferritin levels <45 µg/L at year 3 was greater in the aspirin group (13 versus 9.8 percent); the aspirin group also had a greater overall decline in ferritin by 11.5 percent when compared with those receiving placebo. Similar results were seen in a sensitivity analysis quantifying the effect of aspirin in the absence of major bleeding.
"Daily low-dose aspirin increased the risk for incident anemia by approximately 20 percent, which, after taking into account risk for clinically significant bleeding, was most likely due to occult blood loss given the observed steeper decline in ferritin in participants allocated to aspirin," the authors write.
Several authors disclosed financial ties to industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2023
Read this next
Iptacopan Improves Hematologic, Clinical Outcomes in Persistent Anemia
TUESDAY, March 19, 2024 -- The first-in-class oral factor B inhibitor iptacopan improves hematologic and clinical outcomes in anti-C5-treated patients with persistent anemia and...
USPSTF: Evidence Lacking for Iron Deficiency Screening in Pregnancy
TUESDAY, Feb. 27, 2024 -- The U.S. Preventive Services Task Force concludes there is currently insufficient evidence regarding screening and supplementation for iron deficiency...
AHA: No Real Benefit Seen for Liberal Transfusion Strategy in AMI, Anemia
TUESDAY, Nov. 14, 2023 -- For patients with acute myocardial infarction and anemia, a liberal transfusion strategy does not significantly reduce the risk for recurrent myocardial...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.